Drug Shortage Report for CETROTIDE
Report ID | 25863 |
Drug Identification Number | 02247766 |
Brand name | CETROTIDE |
Common or Proper name | cetrorelix acetate |
Company Name | EMD SERONO, A DIVISION OF EMD INC., CANADA |
Market Status | MARKETED |
Active Ingredient(s) | CETRORELIX |
Strength(s) | 0.25MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | SUBCUTANEOUS |
Packaging size | 1 vial / flacon |
ATC code | H01CC |
ATC description | HYPOTHALAMIC HORMONES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2017-10-12 |
Estimated end date | 2017-12-31 |
Actual end date | 2017-12-01 |
Shortage status | Resolved |
Updated date | 2017-12-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2695 NORTH SHERIDAN WAY, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5K 2N6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2017-12-02 | English | Compare |
v9 | 2017-11-30 | French | Compare |
v8 | 2017-11-30 | English | Compare |
v7 | 2017-10-13 | French | Compare |
v6 | 2017-10-13 | English | Compare |
v5 | 2017-10-13 | English | Compare |
v4 | 2017-10-13 | French | Compare |
v3 | 2017-10-13 | English | Compare |
v2 | 2017-10-13 | English | Compare |
v1 | 2017-10-13 | English | Compare |
Showing 1 to 10 of 10